Cancer Letters

Cancer Letters

Volume 255, Issue 2, 8 October 2007, Pages 295-299
Cancer Letters

High proportion of large genomic rearrangements in hMSH2 in hereditary nonpolyposis colorectal cancer (HNPCC) families of the Basque Country

https://doi.org/10.1016/j.canlet.2007.05.004Get rights and content

Abstract

Hereditary nonpolyposis colorectal cancer (HNPCC), which represents the most common form of inherited colorectal cancer, results from germline alterations of the mismatch repair genes MSH2, MLH1 and MSH6. Rearrangements of MSH2 and MLH1 are involved in at least 10% and 4.3%, respectively, of the HNPCC families fulfilling the Amsterdam (AMS) criteria. We applied a recently developed method, multiplex ligation-dependent probe amplification (MLPA), to study MLH1/MSH2 copy number changes in 29 unrelated Basque Country HNPCC families. We detected six different genomic rearrangements in total (6/29 = 20.69%), four in MSH2 gene (13.79%), and two in MLH1 gene. All of the MSH2 rearrangements were genomic deletions involving several exons. The MLH1 rearrangements were initially detected as one deletion of exon 18 and one deletion of exon 19, but after sequencing analysis, these deletions were not confirmed and corresponded to base pair mutations. We conclude that MLPA is an excellent tool for detecting exon copy number changes in MLH1 and MSH2 in the DNA from HNPCC patients, although all detected rearrangements should be confirmed by an independent molecular methodology. Furthermore, our results in the Basque Country show higher percentages of rearrangements than previously published by other authors.

Introduction

Hereditary nonpolyposis colorectal cancer (HNPCC, Lynch syndrome) is an autosomal dominant disorder which is estimated to account for al least 5% of all cases of colorectal cancer (CRC); in the Spanish population, it appears to be responsible for 2.5% of all cases of CRC [1]. HNPCC is characterised by cancer of the colon, rectum, endometrium, small bowel or urinary tract of early onset. In the majority of cases, Lynch syndrome is caused by germline mutations in the mismatch repair genes (MMR) MLH1, MSH2, MSH6, PMS2 or MLH3[2], with MSH2 and MLH1 being the most important [3]. The MMR genes code for molecules, which repair the errors in the DNA copy. Mutations in these genes inactive the DNA editing function.

Many of the germline mutations described are frameshift, nonsense, splicing or missense. Recently, development of the multiplex ligation-dependent probe amplification (MLPA) technique has enabled large genome rearrangements to be studied. In addition, MLPA enables a greater quantity of sample to be analysed in a shorter period of time, making it possible to observe that these genomic rearrangements account for a significant percentage of the mutations in MSH2 and MLH1[4].

A previous study of the Spanish population performed by Castellvi-Bell et al. [5] revealed a lower frequency of rearrangements in the MSH2 and MLH1 genes (<1.5%) than had been found in other European populations, with frequencies between 15% and 55% [6], [7]. However, few studies on HNPCC have used the MLPA technique. We have therefore undertaken this study on a Basque Country population in order to determine the frequency of large rearrangements in the population with HNPCC. A comparison of the frequency of anomalies was made with the European and Spanish population, as has previously been performed by our group for breast cancer [8].

Section snippets

Families

This study includes a total of 29 unrelated index cases corresponding to: (a) 19 index cases in unrelated families who satisfied Amsterdam criteria I or II for HNPCC; (b) 10 index cases in unrelated families who satisfied the revised criteria of the Bethesda guidelines [9]: and finally we also studied 29 relatives of the positive cases.

Molecular analysis

Informed consent was obtained prior to the extraction of peripheral blood samples for the genetic analyses. Our complete molecular analysis protocol comprises

Results

MLPA analysis of the genome rearrangements for the 29 index cases revealed six cases in which alterations were found, four in MSH2 gene, and two in MLH1 gene. All six positive cases met the Amsterdam criteria. The four rearrangements in MSH2 correspond to deletions, in which more than one exon is lost. The MLH1 rearrangements were initially detected as one deletion of exon 18 and one deletion of exon 19 but, after sequencing analysis, these deletions were not confirmed and correspond to base

Discussion

Although we initially appeared to have found six genomic rearrangements by means of MLPA, in reality there are only four, all of which are in MSH2. Of the alterations in MLH1, one was shown to be a deletion of two base pairs (Fig. 2), and the other, a missense mutation. Although both alterations are pathogenic, they do not constitute large rearrangements. This demonstrates the need to use other techniques to confirm alterations detected by MLPA, particularly in those cases in which the

Acknowledgement

This work was supported by a Grant from the Basque Government Department of Health (Grant No. 200411060).

References (18)

  • R. Burt et al.

    Genetic testing for inherited colon cancer

    Gastroenterology

    (2005)
  • V. Piñol et al.

    Gastrointestinal oncology group of the Spanish gastroenterological association. Frequency of hereditary nonpolyposis colorectal cancer and other colorectal cancer familial forms in Spain: a multicentre, prospective, nation wide study

    Eur. J. Gastroenterol. Hepatol.

    (2004)
  • P. Peltomäki

    Deficient DNA mismatch repair: a common etiologic factor for colon cancer

    Hum. Mol. Genet.

    (2001)
  • G. Kurzawski et al.

    Germline MSH2 and MLH1 mutational spectrum including large rearrangements in HNPCC families from Poland

    Clin. Genet.

    (2006)
  • S. Castellvi-Bell et al.

    The gastrointestinal oncology group of the Spanish gastroenterological association

    Cancer Lett.

    (2005)
  • S. Pistorius et al.

    MLH1 or MSH6 are rare in HNPCC patients carrying point mutations

    Cancer Lett.

    (2006)
  • Y. Wang et al.

    Hereditary nonpolyposis colorectal cancer: frequent occurrence of large genomic deletions in MSH2 and MLH1 genes

    Int. J. Cancer

    (2003)
  • C. Martinez-Bouzas, E. Beristain, I. Guerra, J. Gorostiaga, J.L. Mendizabal, J.L. de Pablo, E. et al., CHEK2 1100delC...
  • R. Umar et al.

    Revised Bethesda guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite instability

    J. Natl. Cancer Inst.

    (2004)
There are more references available in the full text version of this article.

Cited by (14)

  • Genetic alterations in oral squamous cell carcinoma progression detected by combining array-based comparative genomic hybridization and multiplex ligation-dependent probe amplification

    2011, Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology and Endodontology
    Citation Excerpt :

    The development of the MLPA technology has significantly advanced the study of genomic changes in inherited disorders and cancer.12,19,34 Therefore, large chromosomal aberrations may have a direct effect on the expression levels of these adjacent bystander genes; additionally, in expression studies, the possibility of large chromosomal aberrations as a cause of altered expression should be evaluated.35 The genetic alterations induced by MLPA were detected in F3 (1p22), IL1A (2q14), TANK (2q24), PIK3CA (3q26.3), RAD17 (5q13), TNF (6p21.3), MYB (6q22), PTK2 (8q24), CDKN2B (9p21), RELA (11q13), RB1 (13q14.3), ABCC4 (13q32), MESDC1 (15q13), IGF1R (15q26), CDH1 (16q22.1), CRK (17p13.3), TOP2A (17q21.2), NCOA3 (20q13.12), STCH (21q11), and UTY (Yq11.21) in OSCCs (>70%, 5/7 samples).

  • A new strategy to screen MMR genes in Lynch Syndrome: HA-CAE, MLPA and RT-PCR

    2009, European Journal of Cancer
    Citation Excerpt :

    Another finding presented here is that 50% of pathogenic mutations in MSH2 are large genomic deletions, about 42% of the families with deleterious mutation have a deletion. These results in our Spanish population show higher percentages of rearrangements than those previously published by other authors,32 but then again, they are similar to others.33 In this study, we found 20% of variants that we classified as of unknown pathogenic significance (UVs).

  • Report of a germline double heterozygote in MSH2 and PALB2

    2020, Molecular Genetics and Genomic Medicine
View all citing articles on Scopus
View full text